Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression (Q34588606)

3 August 2017

title

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression (English)

1 reference

3 August 2017

0 references

Sung-Wan Kim

1

1 reference

3 August 2017

Il-Seon Shin

2

1 reference

3 August 2017

Jae-Min Kim

3

1 reference

3 August 2017

Young-Chul Kim

4

1 reference

3 August 2017

Kyu-Sik Kim

5

1 reference

3 August 2017

Ki-Min Kim

6

1 reference

3 August 2017

Su-Jin Yang

7

1 reference

3 August 2017

Jin-Sang Yoon

8

1 reference

3 August 2017

publication date

1 February 2008

1 reference

Psychiatry and Clinical Neurosciences

3 August 2017

published in

1 reference

3 August 2017

volume

62

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

75-83

1 reference

Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Prevalence of depression in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Cancer pain, fatigue, distress, and insomnia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Impaired sleep and rhythms in persons with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Contemporary management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Sleep disturbance in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Re: Mirtazapine in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Open trial of mirtazapine in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

The effect of mirtazapine in patients with chronic pain and concomitant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Major depression and insomnia in chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Religiosity, depression and pain in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

The cancer patient with pain: psychiatric complications and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01778.X

10.1111/J.1440-1819.2007.01778.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference